Skip to content

BRIDGE study;BRain Imaging, Development & GEnetics

BRIDGE study;BRain Imaging, Development & GEnetics - BRIDGE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50654
Enrollment
220
Registered
2009-06-15
Start date
2009-12-04
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stemmingsstoornissen brainfunction psychosis

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: All subjects have to satisfy the following criteria in order to participate in the study at baseline: - Between 8-18 years of age - provide written informed consent (by child and parent) - do not have a major medical history - dutch speaking - IQ > 70Specific for offspring of SZ and BD (n =160 in each group): - at least one parent or sibling with a SZ or BD or, - two 2nd degree relatives with BD or SZ Additional criteria for MRI group (n=80 in SZ-group and n=120 in BD-group) of at risk offspring - do not use psychotropic medication - do not have ferrous objects in or around the body (e.g. braces, glasses, metal fragments) - do not have a history of epilepsy in first-degree relatives - no claustrophobiaSpecific for healthy subjects (n =80): - do not have a history of psychiatric illness - do not have a parent or a first-degree family member with a psychotic and/or mood disorder or other psychiatric illness - do not use psychotropic medication - do not have ferrous objects in or around the body (e.g. braces, glasses, metal fragments) - do not have a history of epilepsy in first-degree relatives - no claustrophobia

Exclusion criteria

Exclusion criteria: Exclusion criteria - not dutch speaking - history of closed- or open-head injury - history of neurological illness - IQ

Design outcomes

Primary

MeasureTime frame
-The primary focus of our study is the development of the function of the prefrontal cortex in three different groupos: the offspring and first and second degree relatives of schizophrenic patïents and of bipolar patients, and healthy controls. - psychopathology

Secondary

MeasureTime frame
Secundary study parameters concerning development of at risk offspring and first and second degree relatives, compared to HC offspring: - onset and course of psychopathology, related to family load of psychiatric disorders - immunological and genetic profile of at risk offspring and their parents - effect of stressfull life events on onset and course of psychopathology - neuropsychological parameters (executive functioning and IQ)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)